{
  "CitationSubset": [],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "10157738",
  "DateCompleted": {
    "Year": "1996",
    "Month": "07",
    "Day": "08"
  },
  "DateRevised": {
    "Year": "2007",
    "Month": "11",
    "Day": "15"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "1080-5737",
      "JournalIssue": {
        "Volume": "16",
        "Issue": "1",
        "PubDate": {
          "Year": "1996",
          "Month": "Apr"
        }
      },
      "Title": "Pharmacy practice management quarterly",
      "ISOAbbreviation": "Pharm Pract Manag Q"
    },
    "ArticleTitle": "The American Society of Clinical Oncology guideline program.",
    "Pagination": {
      "StartPage": "31",
      "EndPage": "38",
      "MedlinePgn": "31-8"
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "MD Anderson Cancer Center, University of Texas, Houston 77030, USA."
          }
        ],
        "LastName": "Winn",
        "ForeName": "R F",
        "Initials": "RF"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Smith",
        "ForeName": "T F",
        "Initials": "TF"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Pharm Pract Manag Q",
    "NlmUniqueID": "9508902",
    "ISSNLinking": "1080-5737"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antineoplastic Agents"
    },
    {
      "RegistryNumber": "143011-72-7",
      "NameOfSubstance": "Granulocyte Colony-Stimulating Factor"
    },
    {
      "RegistryNumber": "83869-56-1",
      "NameOfSubstance": "Granulocyte-Macrophage Colony-Stimulating Factor"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "adverse effects",
        "therapeutic use"
      ],
      "DescriptorName": "Antineoplastic Agents"
    },
    {
      "QualifierName": [
        "chemically induced",
        "prevention & control",
        "therapy"
      ],
      "DescriptorName": "Fever"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Granulocyte Colony-Stimulating Factor"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Granulocyte-Macrophage Colony-Stimulating Factor"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "standards"
      ],
      "DescriptorName": "Medical Oncology"
    },
    {
      "QualifierName": [
        "drug therapy"
      ],
      "DescriptorName": "Neoplasms"
    },
    {
      "QualifierName": [
        "chemically induced",
        "prevention & control",
        "therapy"
      ],
      "DescriptorName": "Neutropenia"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Practice Guidelines as Topic"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Societies, Medical"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Treatment Outcome"
    },
    {
      "QualifierName": [],
      "DescriptorName": "United States"
    }
  ]
}